Faximab Injection is a prescription drug, available for use as Injection. Angina, Coronary Artery Disease are some of its major therapeutic uses. Other than this, Faximab Injection has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Faximab Injection. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
The most common side effects of Faximab Injection are Bleeding, Reduced blood platelets, Blurred vision. Apart from the aforementioned side effects, Faximab Injection can also lead to other problems, which have been listed below. Such side effects of Faximab Injection normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Faximab Injection's effect during pregnancy is Unknown and Unknown while nursing. Further, the section on Faximab Injection related warnings talks about Faximab Injection's effects on the liver, heart and kidney.
Faximab Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. Bleeding, Hemorrhagic Cystitis, Thrombocytopenia and ITP are examples of such conditions.
Drug interactions for Faximab Injection have been reported in the medical literature. See below for a complete list.
You should also be aware that Faximab Injection is safe while driving, and is addiction.
Faximab Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Faximab Injection is used -
Severe
Moderate
Common
Is the use of Faximab Injection safe for pregnant women?
The effects of Faximab on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Faximab Injection safe during breastfeeding?
Information about safety of Faximab for women who are breastfeeding is not available since scientific research on this is yet to be done.
What is the effect of Faximab Injection on the Kidneys?
Faximab has very mild side effects on the kidneys.
What is the effect of Faximab Injection on the Liver?
Faximab is rarely harmful for the liver.
What is the effect of Faximab Injection on the Heart?
Faximab is rarely harmful for the heart.
Faximab Injection should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Faximab Injection unless your doctor advises you to do so -
Is this Faximab Injection habit forming or addictive?
No, there is no any evidence that Faximab Injection is addictive.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Faximab Injection since it does not cause drowsiness.
Is it safe?
Yes, Faximab Injection is safe for use.
Is it able to treat mental disorders?
Faximab Injection is unable to treat or cure mental disorders.
Interaction between Food and Faximab Injection
Eating certain foods may increase the time it takes Faximab Injection to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Faximab Injection
Taking Faximab Injection and alcohol together may cause some problems. If you notice any of these side effects, it is best to go to your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Abciximab
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 631